Galderma stock: Shareholders approve dividend and board elections

Galderma stock: Sales outlook raised after strong nine-month ...
Galderma stock: Strong Q3 growth lifts 2026 sales outlook ...
Galderma stock: 2026 sales outlook rises after strong Q3 ...
Bank of America raises target for Galderma stock from CHF ...
Galderma raises 2026 outlook: Galderma stock trades at EUR ...
Galderma stock pre-market at EUR 205.50: dermatology group ...
Morningstar lifts fair value for Galderma stock to CHF 135.00 ...
Galderma raises 2026 sales guidance. Galderma stock is valued ...
Galderma stock pre-market at EUR 209.25: dermatology business ...